Stockreport

Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference

Larimar Therapeutics, Inc.  (LRMR) 
PDF BALA CYNWYD, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developin [Read more]